Lupin application for Pegfilgrastim biosimilar accepted by USFDA Ruchika Sharma3 Jun 2021 12:13 PM ISTMumbai: Global pharma major, Lupin Limited, has recently announced that the USFDA has accepted the Biologics License Application (BLA) for its...
Lupin gets USD 50 million milestone payment from Boehringer Ingelheim for anti-cancer drug Ruchika Sharma27 May 2021 12:24 PM ISTMumbai: Global pharma major Lupin Limited today announced the achievement of key milestones for Lupin's MEK inhibitor compound (LNP3794) that is...
Lupin gets CDSCO panel nod to bioavailability study of Remdesivir Oral Solution for COVID 19 Medical Dialogues Team6 April 2021 5:57 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has opined for the grant of...
Setback to Lupin: CDSCO Panel rejects Rabeprazole Sodium, Acotiamide Hydrochloride Hydrate FDC Medical Dialogues Team4 April 2021 11:30 AM ISTNew Delhi: In a setback to drugmaker Lupin Ltd, the Subject Expert Committee (SEC) functional under Central Drugs Standard Control Organization...
LupinLife to promote hand hygiene in partnership with Uttarakhand Police Ruchika Sharma25 March 2021 12:44 PM ISTMumbai: LupinLife, consumer healthcare business of global pharma major Lupin Limited, has recently announced its association with the Uttarakhand...
Lupin launches generic diarrhea drug Nitazoxanide Ruchika Sharma10 March 2021 4:47 PM ISTMumbai, Baltimore: Global pharma major, Lupin Limited, today announced the launch of the authorized generic version of Alinia (nitazoxanide)...
Lupin Pharma Canada, Endoceutics enter partnership for commercialization of Intrarosa Ruchika Sharma10 March 2021 12:00 PM ISTMumbai, Quebec, Canada: Lupin Pharma, a subsidiary of global pharma major Lupin Ltd, has recently announced a partnership with Endoceutics, a women's...
Etanercept in COVID19 patients: CDSCO Committee tells Lupin to submit revised phase 2 CT protocol Medical Dialogues Team9 March 2021 5:40 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under Central Drug Standard Organization (CDSCO), has recently suggested drug major Lupin...
JIFFY.ai ties up with lupin for AUTOMATE Solution Ruchika Sharma4 March 2021 2:02 PM ISTBengaluru: Global pharma major Lupin Limited and Silicon Valley-based enterprise automation start-up JIFFY.ai have announced a formalized partnership...
Lupin launches generic equivalent of Depen Tablets Ruchika Sharma2 March 2021 4:39 PM ISTMumbai: Global pharma major, Lupin Limited, today announced the launch of Penicillamine Tablets USP, 250 mg, having received an approval from the...
Lupin gets USFDA nod for generic equivalent of Northera Capsules Ruchika Sharma20 Feb 2021 11:25 AM ISTMumbai, Baltimore: Global pharma major, Lupin Limited, has recently announced that the company has received approval for its Droxidopa Capsules, 100...
Lupin unveils Posaconazole Delayed-Release Tablets Ruchika Sharma18 Feb 2021 11:29 AM ISTMumbai, Baltimore: Global pharma major, Lupin Limited, has recently announced the launch of Posaconazole Delayed-Release Tablets, 100 mg, after its...
